Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1999
Medical Areas: Oncology

View By:YearCompanyConditionsTherapeutic AreasDrug Names


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved January 1999
Treatment Area: Oncology

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.